These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Detection of antibodies against pancreatic islet cells in clinical practice]. Pánczél P; Külkey O; Luczay A; Bornemisza B; Illyés G; Halmos T; Baranyi E; Blatniczky L; Mészáros J; Kerényi Z; Geró L; Tamás G; Hosszúfalusi N; Horváth L; Madácsy L; Romics L Orv Hetil; 1999 Nov; 140(48):2695-701. PubMed ID: 10645715 [TBL] [Abstract][Full Text] [Related]
3. Relation between cellular and humoral immunity to islet cell antigens in type 1 diabetes. Hummel M; Durinovic-Bello I; Ziegler AG J Autoimmun; 1996 Jun; 9(3):427-30. PubMed ID: 8816982 [TBL] [Abstract][Full Text] [Related]
4. First-phase insulin response in young healthy children at genetic and immunological risk for Type I diabetes. Keskinen P; Korhonen S; Kupila A; Veijola R; Erkkilä S; Savolainen H; Arvilommi P; Simell T; Ilonen J; Knip M; Simell O Diabetologia; 2002 Dec; 45(12):1639-48. PubMed ID: 12488953 [TBL] [Abstract][Full Text] [Related]
5. Immunology of diabetes mellitus. Maclaren N Ann Allergy; 1992 Jan; 68(1):5-9. PubMed ID: 1736719 [TBL] [Abstract][Full Text] [Related]
6. High T cell responses to the glutamic acid decarboxylase (GAD) isoform 67 reflect a hyperimmune state that precedes the onset of insulin-dependent diabetes. Honeyman MC; Stone N; de Aizpurua H; Rowley MJ; Harrison LC J Autoimmun; 1997 Apr; 10(2):165-73. PubMed ID: 9185878 [TBL] [Abstract][Full Text] [Related]
7. The importance of diabetes registries and clinical biology for the study and treatment of type 1 (insulin-dependent) diabetes mellitus. Gorus FK Verh K Acad Geneeskd Belg; 1996; 58(5):539-86. PubMed ID: 9008403 [TBL] [Abstract][Full Text] [Related]
8. Antibodies to glutamic acid decarboxylase in at-risk and clinical insulin-dependent diabetic subjects: relationship to age, sex and islet cell antibody status, and temporal profile. Schmidli RS; DeAizpurua HJ; Harrison LC; Colman PG J Autoimmun; 1994 Feb; 7(1):55-66. PubMed ID: 8198702 [TBL] [Abstract][Full Text] [Related]
9. Young age and HLA markers enhance the risk of progression to type 1 diabetes in antibody-positive siblings of diabetic children. Yamamoto AM; Deschamps I; Garchon HJ; Roussely H; Moreau N; Beaurain G; Robert JJ; Bach JF J Autoimmun; 1998 Dec; 11(6):643-50. PubMed ID: 9878086 [TBL] [Abstract][Full Text] [Related]
10. [IA-2 and anti-GAD antibodies in patients with newly diagnosed type 1 diabetes and their first degree relatives]. Kretowski A; Kowalska I; Peczyńska J; Urban M; Kinalska I Przegl Lek; 2000; 57(3):143-6. PubMed ID: 10909282 [TBL] [Abstract][Full Text] [Related]
11. Diabetes in the parents of children with Type I diabetes. Douek IF; Gillespie KM; Bingley PJ; Gale EA Diabetologia; 2002 Apr; 45(4):495-501. PubMed ID: 12032624 [TBL] [Abstract][Full Text] [Related]
12. Autoantibodies in type 1 diabetes. Taplin CE; Barker JM Autoimmunity; 2008 Feb; 41(1):11-8. PubMed ID: 18176860 [TBL] [Abstract][Full Text] [Related]
13. Strategies for preventing type I diabetes mellitus. Verge CF; Eisenbarth GS West J Med; 1996 Mar; 164(3):249-55. PubMed ID: 8775937 [TBL] [Abstract][Full Text] [Related]
14. Islet autoantibodies, nationality and gender: a multinational screening study in first-degree relatives of patients with Type I diabetes. Williams AJ; Bingley PJ; Moore WP; Gale EA; Diabetologia; 2002 Feb; 45(2):217-23. PubMed ID: 11935153 [TBL] [Abstract][Full Text] [Related]
16. Poor beta-cell function after the clinical manifestation of type 1 diabetes in children initially positive for islet cell specific autoantibodies. The Childhood Diabetes in Finland Study Group. Komulainen J; Knip M; Lounamaa R; Vähäsalo P; Karjalainen J; Sabbah E; Akerblom HK Diabet Med; 1997 Jul; 14(7):532-7. PubMed ID: 9223390 [TBL] [Abstract][Full Text] [Related]
17. Immunoreactivity to a 64,000 Mr human islet cell antigen in sera from insulin-dependent diabetes mellitus patients and individuals with abnormal glucose tolerance. Baekkeskov S Mol Biol Med; 1986 Apr; 3(2):137-42. PubMed ID: 3526081 [TBL] [Abstract][Full Text] [Related]
18. Cytoplasmic islet cell antibodies remain valuable in defining risk of progression to type 1 diabetes in subjects with other islet autoantibodies. Pietropaolo M; Yu S; Libman IM; Pietropaolo SL; Riley K; LaPorte RE; Drash AL; Mazumdar S; Trucco M; Becker DJ Pediatr Diabetes; 2005 Dec; 6(4):184-92. PubMed ID: 16390386 [TBL] [Abstract][Full Text] [Related]
19. Insulin autoantibodies: evidence of autoimmune disease among a group of Puerto Rican children with newly diagnosed type 1 diabetes mellitus. González de Pijem L; Nieves-Rivera F P R Health Sci J; 2001 Jun; 20(2):161-4. PubMed ID: 11561476 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of islet-specific autoantibodies in Japanese patients with insulin-dependent diabetes mellitus: a comparison between autoantibodies to glutamic acid decarboxylase, autoantibodies to 64 kDa islet cell protein and islet cell antibodies. Kawasaki E; Takino H; Yano M; Uotani S; Matsumoto K; Yamaguchi Y; Akazawa S; Nagataki S J Autoimmun; 1994 Dec; 7(6):791-802. PubMed ID: 7888036 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]